Stockreport

End of Zepbound Shortage Threatens $1 Billion Knockoff Weight-Loss Shot Industry [BNN Bloomberg (Canada)]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Lilly is now able to produce enough of its blockbuster obesity and diabetes medicines that the nationwide shortage of Mounjaro and Zepbound is officially over. As a res [Read more]